VEGFA and cancer: Therefore, novel effective vaccines are being developed based on peptides that mimic the binding sites and signaling mechanisms of VEGF and its receptors; these minimize the off-target effects and associated toxicities, leading to better clinical outcomes for cancer patients [111,131,132].